Biotechnology News

April 10, 2012

NORWALK, Conn. & LEXINGTON, Mass.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium announced the start of a clinical trial evaluating ganetespib developed by Synta (SNTA) as a single agent and in combination with Velcade in multiple...

April 10, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its second quarter of fiscal year...

April 10, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--PharmaVigilant, Spectrum Pharmaceuticals, I-Vault, eTMF, e-clinical, oncology, clinical trials

April 10, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--New FX-5A "Reverse Cholesterol Transport" therapeutic for heart disease and atherosclerosis wins substantial NIH development grant, using body’s natural process for removing unwanted cholesterol

April 10, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announced proposed public offering of shares.

April 10, 2012

MCMINNVILLE, Tenn.--(BUSINESS WIRE)--Vilex announces the launch of the FUZE (TTC Arthrodesis Compression Nail). The latest in its' innovative line of orthopaedic products.

April 10, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) will host a Research and Development Day for the investment community on Tuesday, April 17, 2012 from 10:00 a.m. to 1:00 p.m. at The Four Seasons Hotel in New York City....

April 10, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it will exhibit at the Midwest Podiatry...

April 10, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir Annual Report 2011 is now available at the company’s website: www.medivir.se. Annual Report 2011...

April 10, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Phase 2 data from Provectus's PV-10 clinical trial for metastatic melanoma will be presented at the HemOnc Today Conference on April 13, 2012 in New York City.

April 10, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Global Market for Neurodegenerative Therapies to Exceed $43.4 Billion by 2015

April 10, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced the appointment of Alessandro E. Della Chà and Matthew W. Strobeck, Ph.D., to the company’s board of directors, increasing its board membership to nine. “We welcome our new...

April 10, 2012

STEVENAGE, England--(BUSINESS WIRE)--Novella Clinical, Inc., a full service contract research organisation (CRO), today announced John Sulola has joined as business development director.

April 10, 2012

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--MEDIAN Technologies and CANON will introduce the LMS solutions at ITEM (International Technical Exhibition of Medical Imaging), April 13-15, 2012, Yokohama, Japan

April 9, 2012

SEATTLE--(BUSINESS WIRE)--Sage Bionetworks, Mount Sinai School of Medicine (MSSM), University of Pennsylvania (Penn), the National Institute of Mental Health (NIMH), and Takeda Pharmaceuticals Company Limited (TAKEDA) have launched a Public-...

April 9, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Report Q1 2012 Earnings on May 1, 2012

April 9, 2012

SEATTLE--(BUSINESS WIRE)--April 9, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced that management will host a conference call on Monday, May 7, 2012, at 4:30 p.m. EDT to review first quarter financial results. Access to the discussion...

April 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex (Nasdaq: VRTX) will announce its first quarter 2012 financial results on Thursday, April 26, 2012 after the financial markets close.

April 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem to present at BD Biotech Conference April 17-18, 2012 in Boston, MA.

April 9, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it has received a $50 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop...

April 9, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)--Outpatient Diagnostic Center of Nashville (“ODC Nashville”) announced today the completion of its interior renovations and the upgrade of its Magnetic Resource Imaging (MRI) equipment to the latest, top of the...

April 9, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Group has acquired the assets of General BioTechnology LLC and launched a new company, Cook General BioTechnology LLC (CGBT).

April 9, 2012

HAWTHORNE, N.J.--(BUSINESS WIRE)--Proteonomix, Inc. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today provided updates on its progress. UMK-121: We are...

April 9, 2012

PROVIDENCE, R.I.--(BUSINESS WIRE)--Ximedica appoints Randall S. Barko as new CEO.

April 9, 2012

LOS ANGELES--(BUSINESS WIRE)--Investigators at Children’s Hospital Los Angeles have found a novel approach to killing ALL cells. It may offer a future alternative to patients who become resistant to chemotherapy.

April 9, 2012

BOSTON--(BUSINESS WIRE)--Stealth Peptides Inc. reported today on three clinical studies demonstrating that Bendavia does not affect the pharmacodynamics of several commonly used drugs.

April 9, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today is sending a letter from its Board of...

April 9, 2012

CAMPBELL, Calif.--(BUSINESS WIRE)--Former CEO of PEAK Surgical, acquired by Medtronic, becomes CEO of ZipLine™ Medical

April 9, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that Roche/Genentech/Daiichi Sankyo/Chugai's Zelboraf, which received approval by the U...

April 9, 2012

BALTIMORE--(BUSINESS WIRE)--Marc Davidson hired as Chief Technology Officer at CSA Medical

April 9, 2012

LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation (OTCBB:HEMA) announced today that it filed a Form 15 with the Securities and Exchange Commission (the “SEC”) to voluntarily deregister its shares of common stock under the Securities Exchange Act...

April 9, 2012

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical sells additional MicroThermX® Microwave Ablation System to Synapse Medical Ltd., a subsidiary of SISK Healthcare.

April 9, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Shimadzu Scientific Instruments announces today the grand opening of the Shimadzu Center for Advanced Analytical Chemistry at The University of Texas at Arlington.

April 9, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--Value Plastics, a Nordson Company (Nasdaq: NDSN), announces that they have signed a new distributor, John Morris Scientific Pty Ltd (JMS), to strengthen their presence in Australia and New Zealand.

April 9, 2012

MONTREAL--(BUSINESS WIRE)--Sunshine Biopharma Inc. (OTCBB: SBFM) is pleased to announce that it has recently received notification that the United States Patent and Trademark Office has issued a “Notice of Allowance” for the patent application...

April 9, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced that Michael T. Heffernan, R.Ph. has been appointed to the company’s board of directors, effective...

April 9, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced today that the Company has received an issued patent in Mexico and allowances of three additional patent...

April 9, 2012

NEW YORK--(BUSINESS WIRE)--Galena Biopharma Announces Pricing of Public Offering of Common Stock. Rodman acts as co-manager.

April 9, 2012

EXTON, Pa.--(BUSINESS WIRE)--Nuron Biotech has in-licensed a gene-based amyloid beta vaccine as a treatment for Alzheimer's. The vaccine has a lower immune response than other vaccines and might reduce plaque formation about 50%.

April 9, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer enters agreement with TPMB to validate Halal screening-enabling technologies.

April 9, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on...

April 9, 2012

CHICAGO--(BUSINESS WIRE)--iBIO and PROPEL announced today the four finalists for the 2012 PROPEL Business Plan Competition; Advanced Cooling Therapy, Citrics Biomedical, Shamrock Structures and Vidasym.

April 9, 2012

SEATTLE--(BUSINESS WIRE)--NanoString appointed Joseph M. Beechem, Ph.D. as Senior Vice President of R&D and responsible for establishing and executing the company’s technology and product roadmaps for its nCounter system.

April 6, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Roche (SIX: RO, ROG; OTCQX: RHHBY) released the following statement in response to a report issued by Institutional Shareholder Services (“ISS”) recommending that shareholders of Illumina, Inc. (NASDAQ: ILMN)...

April 6, 2012

LYON, France--(BUSINESS WIRE)--The MEDICREA Group (FR0004178572 - ALMED), listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies,...

April 6, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board, President and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and Business Development, Chief...

April 6, 2012

SEATTLE, & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Presage Biosciences, a leader in identifying clinically viable oncology drug combinations, today announced that it has entered into a cancer research agreement with Millennium: The Takeda Oncology...

April 5, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in operative surgical robotics, will hold its quarterly conference call to discuss First Quarter 2012 results, Tuesday, April 17, at 4:30 p.m. Eastern Time....

April 5, 2012

NEW YORK--(BUSINESS WIRE)--Tonix Pharmaceuticals has completed a pharmacokinetic study on new formulation of its lead drug TNX-102 for the treatment of fibromyalgia